Articles related to RISK ASSESSMENT

Recent findings indicate that statin-naïve ACS patients with normal LDL-C levels at admission may face worse outcomes, challenging current perspectives on lipid management in cardiovascular care.

Statins remain a cornerstone of cardiovascular disease prevention, but managing potential side effects is key to ensuring patient adherence and optimal outcomes. This article provides a comprehensive overview of statin-associated adverse effects and practical management strategies for clinicians.

A comprehensive study spanning over two decades has found no evidence that daily multivitamin use reduces the risk of death from any cause, including cancer and cardiovascular disease.

The introduction of the PREVENT equations could reduce the number of adults eligible for statin therapy by nearly 40%, impacting clinical guidelines and patient care strategies.

Increased daily olive oil consumption is associated with a 28% lower risk of dementia-related mortality, providing potential cognitive health benefits even after adjusting for genetic risk factors.

The Body Roundness Index (BRI) may offer a more precise alternative to BMI, correlating strongly with mortality risk and providing a clearer picture of central adiposity’s impact on health.